[1]
2026. FUNDAMENTAL PARADIGMS IN CLINICAL PHARMACOLOGY: A DUAL PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF POLYPHARMACY IN CHRONIC METABOLIC DISORDERS. ResearchJet Journal of Analysis and Inventions. 7, 5 (May 2026), 1–8. DOI:https://doi.org/10.17605/.